News

Panel backs approval of alirocumab, biologic injectable lipid-lowering drug


 

AT AN FDA ADVISORY COMMITTEE MEETING

References

Pages

Next Article:

FDA panel set to review two biologic lipid-lowering drugs for approval

Related Articles